Anavex Life Sciences Corp (AVXL)

[kevindenver]

I'm excited to hear more about the MJFF biomarker breakthrough that can "objectively and reliably detecting the disease at the molecular level — even before the onset of symptoms."
This discovery will no doubt become integral to trial design and patient selection in the future. But, I read it may take up to 2 years to scale up the technology for use.

In the meantime, the MJFF partners in Australia, "Shake it up foundation" are finalizing the trial design on a Phase 3 PD trial using an already "compelling suite" of biomarkers.

https://shakeitup.org.au/new-treatment-shows-clinical-benefit-in-patients-parkinsons-disease-dementia/